James Krueger
Dermatology · New York, NYNPI 1821307703
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $547,059 of the $671,913 with a category attached, or 81.4%. It is spread thinly across 33 manufacturers, the largest accounting for just 15.4%. Among dermatology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 678 payments — averaging $991.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$104K
- AbbVie$77K
- Boehringer Ingelheim International GmbH$57K
- Boehringer Ingelheim$52K
- Janssen Global Services, LLC$46K
- UCB SA$43K
- plus $293K from 27 others
Across 77 payments — averaging $77,380 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$2.4M
- AbbVie$1.2M
- Takeda Pharmaceuticals U.S.A., Inc.$859K
- Novartis Pharma AG$618K
- Pfizer$464K
- Bausch Health US, LLC$297K
- plus $104K from 6 others
What the payments were for
- Consulting fees$547,05981%
- Speaking & faculty fees$54,7978%
- Travel & lodging$61,3569%
- Food & beverage$7,6761%
- Education$1,0250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 64 | $103,788 |
| AbbVie | 122 | $76,733 |
| Boehringer Ingelheim International GmbH | 74 | $56,744 |
| Boehringer Ingelheim | 24 | $52,110 |
| Janssen Global Services, LLC | 39 | $45,684 |
| UCB SA | 29 | $43,480 |
| Johnson & Johnson | 61 | $42,304 |
| Novartis | 42 | $37,421 |
| Amgen | 57 | $31,771 |
| Janssen Scientific Affairs, LLC | 4 | $23,369 |
| Eli Lilly | 9 | $19,132 |
| Almirall LLC | 4 | $17,831 |
| LEO Pharma AS | 33 | $15,630 |
| Sanofi | 9 | $15,281 |
| Merck | 11 | $14,225 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $11,547 |
| UCB, Inc. | 7 | $9,127 |
| Sanofi-aventis U.S. LLC | 3 | $8,829 |
| Incyte Corporation | 19 | $6,437 |
| Bristol Myers Squibb | 25 | $6,346 |
| Kyowa Kirin Co., Ltd | 5 | $5,687 |
| Calliditas Therapeutics US Inc. | 2 | $5,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $4,414 |
| Pfizer | 8 | $4,399 |
| Novartis Pharma AG | 3 | $4,270 |
| CSL Behring | 2 | $3,000 |
| Janssen Research & Development, LLC | 2 | $2,790 |
| UCB GmbH | 1 | $2,490 |
| Kyowa Kirin, Inc. | 1 | $740 |
| LEO Pharma Inc. | 4 | $633 |
| Regeneron | 3 | $319 |
| Regeneron Healthcare Solutions, Inc. | 4 | $229 |
| Dermira, Inc. | 1 | $154 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$671,913 in reported general payments places this provider in the 95th percentile of 1,151 dermatology providers in New York.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.